Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I‐II gastric cancer after curative gastrectomy
Open Access
- 2 May 2019
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 8 (6) , 2919-2929
Abstract
This study aimed to determine the prognostic value of preoperative plasma fibrinogen concentration (PFC) in patients with stage I‐II gastric cancer after curative gastrectomy. The preoperative PFC and clinicopathological data of 793 patients with stage I‐II gastric cancer who underwent curative gastrectomy were analyzed retrospectively. PFC of <4.0 g/L and ≥4.0 g/L were considered as PFC0 and PFC1, respectively. The association between PFC and the clinicopathological features of gastric cancer and the value of PFC in survival prediction were investigated. PFC1 indicated poorer overall survival and cancer‐specific survival among patients with tumor‐node‐metastasis (TNM) stage I‐II, and PFC was identified as an independent indicator of survival via multivariate analysis. Importantly, PFC stage was proven to be an independent prognostic factor for stage I and T1‐4aN0 gastric cancer. PFC stage combined with the American Joint Committee on Cancer (AJCC)‐TNM stage has better accuracy for predicting disease prognosis than AJCC‐TNM stage alone. The prognosis of patients with stage I‐II gastric cancer can be further stratified by PFC level. For patients with stage I gastric cancer, PFC1 can be considered a high‐risk prognostic factor, and adjuvant chemotherapy should be recommended for patients with PFC1.Keywords
Funding Information
- Natural Science Foundation of Liaoning Province (2015020500)
This publication has 34 references indexed in Scilit:
- High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancerGastric Cancer, 2010
- Colitis-Associated Cancer Is Dependent on the Interplay between the Hemostatic and Inflammatory Systems and Supported by Integrin αMβ2 Engagement of FibrinogenCancer Research, 2010
- The Relationship of Vascular Endothelial Growth Factor and Coagulation Factor (Fibrin and Fibrinogen) Expression in Clear Cell Renal Cell CarcinomaUrology, 2010
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- A meta‐analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatmentCancer, 2007
- Hyperfibrinogenemia is a Useful Predictor for Lymphatic Metastasis in Human Gastric CancerJapanese Journal of Clinical Oncology, 2005
- Antitumor and antimetastatic effect of warfarin and heparinsBiomedicine & Pharmacotherapy, 2004
- Tumors and FibrinogenAnnals of the New York Academy of Sciences, 2001
- Human Fibroblast Adhesion to FibrinogenBiochemistry, 1997
- Vascular Permeability Factor/Vascular Endothelial Growth Factor: An Important Mediator of Angiogenesis in Malignancy and InflammationInternational Archives of Allergy and Immunology, 1995